]>
IRCT20230809059103N1 IRCT 2023-09-28 Shahid Beheshti University of Medical Sciences Investigating the effectiveness of brief acceptance and commitment therapy (ACT) on reducing the symptoms of depression, anxiety, stress, rumination and worry, and increasing the quality of life and the number of CD4 lymphocytes in people with HIV. HIV-ACT Investigating the effectiveness of brief acceptance and commitment therapy (ACT) on reducing the symptoms of depression, anxiety, stress, rumination and worry, and increasing the quality of life and the number of CD4 lymphocytes in people with HIV. 2023-10-22 anticipated 60 Complete https://irct.ir/trial/72055 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: Allocation of people to two groups will be done by block randomization, which will be done by RANDOM ALLOCATION SOFTWARE, in this method, both groups will have the same number of subjects, which will minimize the effect of confounding variables, Blinding description: The participants will not be aware of their allocation to the control and experimental groups, and the people who are in the control group will be told that your intervention (according to the time required to perform interventions on the experimental group) will begin some time later. N/A HIV. Intervention 1: Intervention group: this group is subjected to the same four session ACT treatment intervention. Intervention 2: Control group: After the intervention group, they are subjected to the same treatment measures. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The decision will be made in consultation with the supervisors
public Amirsam Kiani Moghadam
Taleghani Hospital, Arabi Street, Velenjak
Tehran Iran (Islamic Republic of) 1985711151 +98 21 2243 2560 as.kianimoghadam@gmail.com Shahid Beheshti University of Medical Sciences scientific Amirsam Kiani Moghadam
Taleghani Hospital, Arabi Street, Velenjak
Tehran Iran (Islamic Republic of) 1985711151 +98 21 6562 3484 as.kianimoghadam@gmail.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Having informed consent to participate in the research and sign a written consent form Age over 18 years Not having an active addiction Not suffering from severe psychiatric disorders A score equal to or above 9 in the PHQ-9 questionnaire 18 years no limit Both Receiving other treatments at the same time Report suicidal thoughts or intent Absence of more than 3 consecutive sessions Taking psychotropic drugs Unwillingness to participate in treatment B20 Human immunodeficiency virus [HIV] disease Treatment - Other Treatment - Other Intervention group: this group is subjected to the same four session ACT treatment intervention Control group: After the intervention group, they are subjected to the same treatment measures. Symptoms of depression, anxiety, stress,. Timepoint: The beginning and end of the study, TWO months later, six months later and twelve months later. Method of measurement: .Depression: the score that a person gets in the depression subscale of the DAAS questionnaire.Anxiety: the score that a person gets in the anxiety subscale of the DAAS questionnaire.Stress: the score that a person gets in the stress subscale of the DAAS questionnaire. Quality of life. Timepoint: The beginning and end of the study, TWO months later, six months later and twelve months later. Method of measurement: (WHO-QOL-BRIEF). Worry. Timepoint: The beginning and end of the study, TWO months later, six months later and twelve months later. Method of measurement: PSWQ. Rumination. Timepoint: The beginning and end of the study, TWO months later, six months later and twelve months later. Method of measurement: (RRS). CD4 lymphocytes. Timepoint: The beginning and end of the study, TWO months later, six months later and twelve months later. Method of measurement: CD4 count by flow cytometry and complete blood count will be determined by a licensed clinical laboratory in Imam Khomeini Hospital. Shahid Beheshti University of Medical Sciences Approved 2023-07-24 Ethics Committee of Shahid Beheshti University of Medical Sciences Faculty of Medicine - Shahid Beheshti University of Medical Sciences tehran Tehran Iran (Islamic Republic of)